In addition to skeletal muscle dysfunction, recent frameworks describe cancer cachexia as a systemic disease 3 0 involving remodeling of non-muscle organs such as adipose and liver. Impairment of mitochondrial function is 3 1 associated with multiple diseases. The tissue-specific control of mitochondrial function in cancer cachexia is 3 2 not well-defined. This study determined mitochondrial respiratory capacity and coupling control of skeletal 3 3 muscle, white adipose tissue (WAT), and liver in colon-26 (C26) tumor-induced cachexia. Tissues were 3 4 collected from PBS-injected weight-stable mice, C26 mice that were weight-stable, and C26 mice with 3 5 moderate (10% weight loss) and severe cachexia (20% weight loss). WAT showed high non-phosphorylating 3 6 LEAK respiration and reduced respiratory control ratio (RCR, index of OXPHOS coupling efficiency) during the 3 7 induction of cachexia. Liver RCR decreased early due to cancer, and further declined with severe cachexia, 3 8
3
.817) , indicating elevated WAT metabolism in weight-losing mice with smaller myofibers, and 3 7 lower WAT metabolism in weight-stable mice with larger myofibers. Further, RCR for WAT was positively 3 8 associated with body weight change and fiber CSA (r=0.709, r=0.565) (Fig. 6d, j) , whereas the LEAK ratios L/P 3 9 and CI L /CI+II P related inversely with body weight change and fiber CSA (r=-0.628-0.789) ( Fig. 6e-f , k-l), 4 0 suggesting uncoupled WAT mitochondria to be a feature of tumor-induced weight loss and myofiber atrophy. 4 1 4 2
Early loss of liver OXPHOS coupling efficiency and elevated LEAK in C26 mice 4 3
Compared to PBS-WS, mass-specific respiration for CI L , CI P , CI+II P , and CI+II E were ~40-80% lower in 4 4 all three C26 groups, indicating early and sustained loss of liver respiratory capacity due to cancer, and not 4 5 cachexia per se, for each coupling state (i.e. LEAK, OXPHOS, ETS) ( Fig. 7a ). CS activity, a proxy for 4 6 mitochondrial density, was not different between groups (p>0.05) ( Fig. 7e ), suggesting the impairment of liver 4 7 respiratory function to be independent of mitochondrial mass. In agreement, AMPK phosphorylation status, an 4 8 upstream signal for PGC-1α-dependent mitochondrial biogenesis, was not different between groups (p>0.05) 4 9 ( Fig. 9b, e ). RCR of the liver was ~25-60% lower in C26-WS, C26-MOD, and C26-SEV compared to PBS-WS 5 0 ( Fig. 7b ). C26-SEV also had lower liver RCR than C26-MOD ( Fig. 7b ). Together this may signify an early loss 5 1 of OXPHOS coupling efficiency due to cancer, that subsequently worsens when severe cachexia develops. 5 2 CI L /CI+II P was greater in C26-WS (+82%), C26-MOD (+74%), and C26-SEV (+93%) compared to PBS-WS 5 3 ( Fig. 7c ), suggesting an early, sustained increase in the fraction of maximal OXPHOS capacity that is LEAK 5 4 due to cancer rather than cachexia. The P/E ratio (CI+II P /CI+II E ) was greater in C26-SEV compared to all 5 5 other groups (Fig. 7d ). Because P/E in C26-SEV approached 1.0 (0.94±0.05), this may indicate dyscoupled 5 6 liver mitochondria in severe cancer cachexia. 5 7
Mass-specific respiration was positively related to body weight change (r=0.382-0.430) and fiber CSA 5 8 (r=0.395-0.459) , suggesting that cachexia-related weight loss and fiber atrophy may be linked 5 9
to a depression in liver mitochondrial function. Weight change was also positively associated with liver RCR 6 0 (r=0.497), but inversely related to the LEAK ratios L/P (r=-0.569) and CI L /CI+II E (r=-0.484) (Figs. 8d-f), 6 1 suggesting that liver mitochondria with tighter coupling appeared more often in weight-stable mice, whereas 6 2 uncoupling typically appeared with weight loss. 6 3 6 4
Decreased ROS, increased cardiolipin, and greater Ant2 expression in cachectic liver mitochondria 6 5
To identify events associated with uncoupling of OXPHOS and elevated LEAK, we measured H 2 O 2 6 6 production and cardiolipin content by amplex red and NAO fluorescence, respectively, in the mitochondrial 6 7 fraction of the liver. H 2 O 2 is an indicator of mitochondrial ROS emission, and uncoupling may occur as a 6 8 protective response against high levels of ROS. H 2 O 2 was significantly lower in all three C26 groups compared 6 9 to PBS-WS ( Fig. 7f ). H 2 O 2 also showed greater decline during weight loss progression, with C26-MOD ~30% 7 0 lower than C26-WS, and C26-SEV ~40% lower than C26-MOD (Fig. 7f ). This gradual decline in ROS 7 1 emission paralleled decreases in respiratory capacity, and may represent part of a broad, cachexia-associated 7 2 loss of liver mitochondrial function. Therefore, uncoupling was not due to excessive ROS. Cardiolipin, a 7 3 phospholipid of the mitochondrial inner membrane that regulates OXPHOS function, was ~40% greater in C26-7 4 MOD and C26-SEV compared to C26-WS ( Fig. 7g ). The greater cardiolipin content in both groups of 7 5 cachectic mice may support an involvement of this mitochondrial phospholipid in the uncoupling of liver 7 6 OXPHOS in cancer cachexia. We next probed for Ucp2 and Ant2 expression in liver mitochondria by 7 7 immunoblotting to determine whether proteins with reported uncoupling properties may be associated with the 7 8 increased LEAK respiration and uncoupling of OXPHOS ( Fig. 9a ). Ucp2 protein expression was not 7 9 significantly different between groups (p>0.05) ( Fig. 9a, c ). However, Ant2 protein expression was significantly 8 0 greater in C26-SEV compared to PBS-WS, C26-WS, and C26-MOD, by 30%, 15%, and 16%, respectively 8 1 ( Fig. 9a, d ). There was a significant inverse relationship between Ant2 expression and RCR in the liver (r=-8 2 0.547), implying higher liver Ant2 content to be associated with uncoupling of OXPHOS ( Fig. 9f ). 8 3 8 4
Discussion

5
We report tissue-specific alterations in mitochondrial function during colon-26 tumor-induced cachexia. 8 6 WAT showed high rates of mitochondrial respiration during the induction of cancer cachexia. Non-8 7 phosphorylating LEAK respiration of WAT was especially pronounced at this stage. WAT also had reduced 8 8 efficiency of the OXPHOS system as evidenced by decreased RCR, reflecting uncoupling of respiration from 8 9 ATP synthesis, possibly due to greater leakiness of the mitochondrial inner membrane. Together these 9 0 findings are consistent with the presence of uncoupled WAT mitochondria and browning of WAT. RCR of the 9 1 liver decreased early due to cancer, and further declined with severe cachexia. This happened in concert with 9 2 increased Ant2 but not Ucp2 expression. Ant2 also exhibited a significant inverse relationship with RCR, 9 3 suggesting a role for Ant2 in uncoupling of liver OXPHOS in cancer cachexia. Increased liver cardiolipin 9 4 content occurred during moderate cachexia and remained elevated in severe cachexia, indicating that this may 9 5 be an early event that contributes to uncoupling of liver OXPHOS. With the exception of fatty acid based 9 6 respiration, impairment of skeletal muscle mitochondrial respiration was predominant in severe cachexia, and 9 7 this dysfunction resided at complex I. Mitochondrial respiratory parameters of WAT, liver, and skeletal muscle 9 8 accounted for a significant proportion of the variance in body weight change and myofiber size (Figs. 3, 6, 8) . 9 9
These findings suggest that mitochondrial function is subject to tissue-specific control during cancer cachexia, 0 0 whereby early alterations arise in WAT and liver, followed by later impariment of skeletal muscle respiration. 0 1 Skeletal muscle has arguably been the most widely studied organ in cancer cachexia. Several pre-0 2 clinical investigations have examined in situ mitochondrial respiration in skeletal muscle using a cross-sectional 0 3 design comparing controls and tumor-bearing rodents with marked cachexia. Impaired complex I and 0 4 complex II OXPHOS were reported [21, 52] , consistent with a loss of mitochondrial respiratory function in 0 5 severely cachectic skeletal muscle. We expand upon these findings by using a SUIT protocol to evaluate in 0 6 situ respiration across a broader range of coupling states and substrate conditions, in tissue obtained from 0 7 tumor-bearing mice with varying degrees of cachexia. Mass-specific respiration for complex I OXPHOS, and 0 8 complex I+II OXPHOS and ETS were not significantly different in moderate cachexia compared to PBS weight-0 9 stable mice. Significant declines in these variables only occurred in severe cachexia, suggesting that altered 1 0 skeletal muscle mitochondrial respiration is not an early event in cancer cachexia. Indeed, loss of muscle 1 1 mass and fiber CSA were evident in mice with moderate cachexia despite no significant impairment of complex 1 2 I and II linked respiration at this stage. Fatty acid based respiration would be the exception (i.e. FAO L , FAO P ), 1 3 which was reduced in moderate cachexia and remained suppressed in the severe state. 1 4
Since these parameters represent tissue mass-specific fluxes and do not account for mitochondrial 1 5 content, we also calculated flux control ratios by normalization to maximal ETS capacity to provide indices of 1 6 mitochondrial quality that are independent of mitochondrial density. The flux control ratio for complex I 1 7
OXPHOS in skeletal muscle was impaired only in severe cachexia, consistent with the assertion that muscle 1 8 mitochondrial dysfunction occurred with late stage cachexia. In line with complex I dysfunction, the substrate 1 9 control ratio for succinate was ~4-5 fold greater in severe cachexia compared to all other groups, an apparent 2 0 1 6 compensation to stimulate OXPHOS via complex II. Based on the impairment of OXPHOS, we would expect 2 1 energetic stress to be present in skeletal muscle of cachectic mice. Phosphorylation of AMPK was increased 2 2 early, in weight-stable C26 mice, and remained elevated in moderate cachexia, which may imply that energetic 2 3 stress at least partly drives ensuing protein degradation and muscle atrophy. Consistent with energetic stress, 2 4 mitochondrial creatine kinase (CKMT2) expression was elevated ~2-4-fold in moderate cachexia, which could 2 5 represent a compensatory mechanism aiming to improve oxidative energy metabolism in skeletal muscle [48] .
6
A similar expression pattern was seen for Ant2, an ADP transport protein, suggesting that Ant2 may also be 2 7 involved in this compensatory mechanism. In addition to impaired OXPHOS, dysfunctional mitochondria may 2 8 generate high levels of ROS that in turn affects protein turnover and causes atrophy. We did not observe 2 9 increased H 2 O 2 in the mitochondrial fraction of skeletal muscle as anticipated. H 2 O 2 production actually 3 0 declined in moderate and severe cachexia, and does not appear associated with muscle atrophy in this model.
1
The elevated rates of mitochondrial respiration in WAT were not surprising. A recent report found 3 2 increased oligomycin and FCCP induced respiration in white adipocytes treated with parathyroid-like protein, a 3 3 tumor-derived product that induces browning [8] . Others found increased respiratory capacity of brown-like 3 4 WAT in cachectic mice using glycerol-3-phosphate as a substrate [24] . Our data extends these findings by 3 5 using a SUIT protocol to evaluate in situ respiration of WAT in a broader spectrum of coupling and substrates 3 6 states. A unique finding was the increase in coupled (phosphorylating) respiration with electron input through 3 7 complex I and complex I+II, which to our knowledge has not been previously reported. Upregulation of TCA 3 8 cycle, electron transport, and OXPHOS genes in cancer patients with cachexia has been documented by 3 9 others [53], and our elevated OXPHOS and ETS capacities are consistent with that gene profile. The 4 0 increased phosphorylating respiration could be a compensatory response to the lipolysis of WAT. Lipolysis is 4 1 stimulated to mobilize free fatty acids and glycerol into the bloodstream for use by other tissues. Treatments 4 2 that inhibit coupling and ATP synthesis are believed to suppress lipogenesis in adipose tissue [54, 55] . 4 3
Further, insulin-dependent suppression of lipolysis may depend on ATP availability [54, 56] . Thus, increased 4 4 phosphorylating respiration may be a compensatory effort to provide the energy supply to promote lipogenesis 4 5 and/or suppress lipolysis, in order to maintain adipose mass in the face of tumor-induced catabolism.
6
While coupled respiration of WAT increased in early cachexia, the LEAK state showed particularly 4 7 robust expansion. By dividing coupled and LEAK respiration (in the same complex I-linked substrate 4 8 1 8
peroxidation [57] . We are unable to address whether changes in composition occurred, however the 7 7 decreased H 2 O 2 in liver mitochondrial lysates during cachexia suggests minimal peroxidation due to 7 8 mitochondrial ROS emission. Treatment of normal liver mitochondria with cardiolipin-enriched liposomes has 7 9 been shown to adversely affect ATP synthesis and increase non-phosphorylating respiration, offering a 8 0 possible explanation for the significance of enhanced liver cardiolipin in cancer cachexia [58, 59] . 8 1
The role of Ant in mediating cachexia-associated energy wasting has received some attention [59] . Ant 8 2 is an ADP/ATP exchanger in the inner mitochondrial membrane that has uncoupling capability. Treatment of 8 3 liver mitochondria from cachectic rats with carboxyatractylate, an inhibitor of Ant, did not mitigate energy 8 4
wasting, suggesting that Ant is not the predominant contributor to energetic inefficiency of liver mitochondria 8 5 from cachectic rodents. The authors therefore concluded that inefficiency of OXPHOS and energy wasting 8 6 was dependent on cardiolipin, but not Ant. However, we saw increased Ant2 expression in severe cachexia, 8 7 which would point to an involvement of this molecule in the elevated LEAK state and loss of OXPHOS coupling 8 8 efficiency. This is supported by the significant inverse relationship between Ant2 and RCR in the liver. Direct 8 9 manipulations of liver Ant2 are necessary to better understand the role of this molecule in OXPHOS function in 9 0 cancer cachexia. We also expected to see increased Ucp2 expression in liver mitochondria from C26 mice 9 1 with cachexia. Although Ucp2 expression was ~2-fold greater in C26 mice compared to PBS-WS, this did not 9 2 reach statistical significance. Therefore, the increased LEAK respiration and uncoupling of OXPHOS does not 9 3 appear to be mediated by Ucp2, at least in colon-26 tumor-induced cachexia. These findings bring attention to 9 4 the previously underappreciated role of liver mitochondrial function in cancer cachexia, and suggest a benefit 9 5 of therapies that improve mitochondrial function of the liver. 9 6
In conclusion, we provide evidence for tissue-specific control of mitochondrial function in colon-26 9 7 tumor-induced cachexia. Impairment of skeletal muscle mitochondrial OXPHOS occurred predominantly in 9 8 severe, late stage cachexia, whereas alterations to WAT and liver arise earlier and could contribute to altered 9 9 whole body energy balance and involuntary weight loss characteristic of cancer cachexia. Together these 0 0 findings suggest mitochondrial function of multiple tissues to be potential sites of targeted therapies. 
